series-c-plus
Stage
2018
Founded
7
Investors
About
Nouscom is a clinical-stage immuno-oncology company developing next-generation, off-the-shelf and personalized viral vector-based cancer vaccines. These vaccines target neoantigens for the prevention and treatment of cancer.
Explore Nouscom's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.